Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Clinical Trial Highlights - GLP-1 agonists
Nischal, N., Gupta, S., Lal, K
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size
The drug has been approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
The goal is sustainable behaviour change that persists regardless of medication status
US$ 29.12
US$ 24.90
US$ 25.62
US$ 22.39
US$ 29.26
US$ 27.63
US$ 20.38
US$ 27.67
US$ 25.85
